Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: A review

Document Type

Article

Publication Date

2-1-2021

Abstract

Antimicrobial resistance (AMR) threatens the effective prevention and treatment of a wide range of infections. Governments around the world are beginning to devote effort for innovative treatment development to treat these resistant bacteria. Systems biology methods have been applied extensively to provide valuable insights into metabolic processes at system level. Genome-scale metabolic models serve as platforms for constraint-based computational techniques which aid in novel drug discovery. Tools for automated reconstruction of metabolic models have been developed to support system level metabolic analysis. We discuss features of such software platforms for potential users to best fit their purpose of research. In this work, we focus to review the development of genome-scale metabolic models of Gram-negative pathogens and also metabolic network approach for identification of antimicrobial drugs targets.

Keywords

Novel antimicrobial, Genome-scale metabolic model, Gram-negative pathogens

Publication Title

Journal of Antibiotics

Divisions

pharmacy

Funders

Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia (FRGS/1/2019/SKK11/TAYLOR/03/1)

Volume

74

Issue

2

Publisher

Spring Nature

Publisher Location

CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND

This document is currently not available here.

Share

COinS